Background Image
Menu

Latest News

Blueberry Therapeutics Announce Positive Results from a Phase I-II Clinical Trial

22 November 2018

Blueberry Therapeutics Announce Positive Results from a Phase I-II Clinical Trial

Alderley Park, UK, 21stNovember 2018– Blueberry Therapeutics Limited (“Blueberry Therapeutics”), a modern drug discovery and development company committed to the development of innovative new therapies for the treatment of common and difficult to treat...

Biofilm seals £2.5m funding injection

19 November 2018

Biofilm seals £2.5m funding injection

Biofilm has secured a £2.5 million funding package to increase production capacity and expand its product range. Biofilm, which was originally launched as a subsidiary of food products firm Devro, specialises in fast dissolving and absorbable films for use in food...

R2C Online wins at 2018 Commercial Motor Awards

19 November 2018

R2C Online wins at 2018 Commercial Motor Awards

Delighted to announce that Catapult portfolio company R2C Online have won the award for Workshop Innovation of the Year at the 2018 Commercial Motor Awards. Read more about the event and the winners here:

YProtech receives £400k funding boost

8 November 2018

YProtech receives £400k funding boost

A high value chemistry services company based at Alderley Science Park has secured £400,000 of funding. YProtech (YPT) was founded in 2011. The core of the company's business relates to those operating in the pharmaceutical, biotechnology and applied chemistry...

UMI3 Ltd showcases innovations to Catapult Ventures

10 October 2018

UMI3 Ltd showcases innovations to Catapult Ventures

Investors meet University of Manchester academic entrepreneurs … On 3rd October UMI3 Ltd held an investor day with Catapult Ventures, who manage the Greater Manchester & Cheshire Life Sciences Fund, to hear from the CEOs of two of their portfolio companies and to showcase a...

Clin-e-cal announces investment from Catapult Ventures to advance its pipeline of innovative digital health respiratory applications

9 October 2018

Clin-e-cal announces investment from Catapult Ventures to advance its pipeline of innovative digital health respiratory applications

Alderley Park, UK – 3 rd Octo ber 2018. Clin-e-cal, an innovative digital health company, today announced the completion of a new funding round to expand its development of a fundamentally new approach to training and compliance in respiratory medicine. The funding came...

Yospace Provides IBC Award-Winning Solution For Medialaan

2 October 2018

Yospace Provides IBC Award-Winning Solution For Medialaan

Belgian TV Everywhere provider Medialaan took the highly coveted IBC2018 Innovation Award for Content Distribution for its remarkable advertising management system, developed using Yospace technology. Staines-upon-Thames, UK – 26 September 2018: Belgian TV Everywhere...

Cytox expands collaboration with AIBL to identify those most at risk to rapidly progress to Alzheimer’s

25 September 2018

Cytox expands collaboration with AIBL to identify those most at risk to rapidly progress to Alzheimer’s

Oxford & Manchester, UK. Cytox, a precision medicine company which today is commercializing polygenic risk scoring (PRS) approaches for assessing genetic risk for developing Alzheimer’s and other neurological diseases, has announced it has expanded its research...

NPIF - Maven Equity Finance and Catapult Ventures, alongside new Manchester Tech Trust angel group, invest £700,000 in Biorelate

18 September 2018

NPIF - Maven Equity Finance and Catapult Ventures, alongside new Manchester Tech Trust angel group, invest £700,000 in Biorelate

Manchester-based technology platform creates innovative solution for data curation in biomedicine … NPIF - Maven Equity Finance, managed by Maven Capital Partners (“Maven”) and part of the Northern Powerhouse Investment Fund, has invested £200,000 as part of a...

GM&C Life Sciences Fund announces 25th investment

13 September 2018

GM&C Life Sciences Fund announces 25th investment

Investment in digital healthcare company Rinicare is milestone deal for Fund … Alderley Park, UK, 13th September 2018 – The GM&C Life Sciences Fund, managed by Catapult Ventures, has announced its 25th investment by completing the funding of Alderley Park based...